[
  {
    "ts": null,
    "headline": "USA Vaccine Market Outlook Report 2025-2030 | Focus on Lassa Fever, Ebola, RSV Vaccines, Alongside Genomics-Driven Targeted Therapies, Strengthens Public Health Preparedness and Investment Potential",
    "summary": "The USA vaccine market is valued at USD 30 billion, driven by health initiatives, disease awareness, and tech advancements. Pfizer, Moderna, and Johnson & Johnson lead, benefiting from R&D prowess and distribution. Growth is spurred by government funding and emerging vaccine innovation, despite challenges like hesitancy and supply disruptions.Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The \"USA Vaccine Market outlook to 2030\" report has been added to ResearchAndMarkets.com's offering.The USA vacc",
    "url": "https://finnhub.io/api/news?id=01b26b6d1e3a658e5fc5e6bd543ec22d3ebf9d02471ad137d9b2234ecaf9ab3c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757413260,
      "headline": "USA Vaccine Market Outlook Report 2025-2030 | Focus on Lassa Fever, Ebola, RSV Vaccines, Alongside Genomics-Driven Targeted Therapies, Strengthens Public Health Preparedness and Investment Potential",
      "id": 136688676,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The USA vaccine market is valued at USD 30 billion, driven by health initiatives, disease awareness, and tech advancements. Pfizer, Moderna, and Johnson & Johnson lead, benefiting from R&D prowess and distribution. Growth is spurred by government funding and emerging vaccine innovation, despite challenges like hesitancy and supply disruptions.Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The \"USA Vaccine Market outlook to 2030\" report has been added to ResearchAndMarkets.com's offering.The USA vacc",
      "url": "https://finnhub.io/api/news?id=01b26b6d1e3a658e5fc5e6bd543ec22d3ebf9d02471ad137d9b2234ecaf9ab3c"
    }
  }
]